Tools
Tools
Savulich, G., Piercy, T., Brühl, A. B., Fox, C. 
ORCID: https://orcid.org/0000-0001-9480-5704, Suckling, J., Rowe, J. B., O'Brien, J. T. and Sahakian, B. J.
(2017)
Focusing the neuroscience and societal implications of cognitive enhancers.
Clinical Pharmacology and Therapeutics, 101 (2).
170–172.
ISSN 0009-9236
Preview |
PDF (Accepted manuscript)
- Accepted Version
Download (991kB) | Preview |
Abstract
Cognitive enhancement can benefit the individual and society, but also has associated risks and ethical concerns. Cognitive-enhancing drugs are used in the treatment of neuropsychiatric disorders. Non-pharmacological strategies are also emerging, which have the potential to improve motivational deficits associated with neuropsychiatric symptoms and should be prioritized for development. The increasing lifestyle use of ‘smart’ and other drugs indicates the desire for healthy people to improve themselves. Safety and ethical implications are discussed.
| Item Type: | Article |
|---|---|
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| Depositing User: | Pure Connector |
| Date Deposited: | 24 Sep 2016 00:54 |
| Last Modified: | 21 Oct 2022 06:33 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/60269 |
| DOI: | 10.1002/cpt.457 |
Actions (login required)
 |
View Item |